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Abstract 
Ribotoxins are a family of fungal extracellular ribonucleases which inactivate ribosomes 
by specifically cleaving a single phosphodiester bond located at the universally 
conserved sarcin/ricin loop of the large rRNA. The subsequent inhibition of protein 
biosynthesis is followed by cell death via apoptosis. Ribotoxins are also able to interact 
with membranes containing acid phospholipids, their cytotoxicity being preferentially 
directed towards cells showing altered membrane permeability, e.g. transformed or 
virus infected cells. Many features of their cytotoxic action and their ribonucleolytic 
mechanism have been elucidated by comparison with other extracellular non toxic 
fungal RNases, best represented by RNase T1. The study of structure-function 
relationships in ribotoxins is of particular interest, since they are postulated as potential 
therapeutic agents against different human pathologies. The production of 
hypoallergenic variants with application in several Aspergillus-related allergic 
syndromes and the construction of immunotoxins against different carcinomas are 
promising examples of such potential therapeutic utilisation.  
 
Introduction 
In 1963, during a screening program started seven years earlier by the Michigan 
Department of Health searching for new antibiotics and antitumour agents, the culture 
filtrates of a mould isolated from a sample of a Michigan farm soil were found to 
contain a substance inhibitory to both sarcoma 180 and carcinoma 755 induced in mice 
(Jennings et al., 1965; Olson and Goerner, 1965). The mould was identified as a strain  
of Aspergillus giganteus and the protein responsible for these effects was named α-
sarcin (Olson and Goerner, 1965). Two other antitumour proteins with similar activities, 
restrictocin and mitogillin, both produced by Aspergillus restrictus, were later found, 
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and came to be part of a new family of proteins, today called ribotoxins, which would 
be joined much later by Asp f 1, identified three decades after as one of the major 
allergens of Aspergillus fumigatus (Arruda et al., 1992).  The unspecificity exhibited by 
these proteins in their cytotoxic action (Roga et al., 1971) caused the abandon of their 
study until the mid-1970s, when it was demonstrated that they were capable of 
inhibiting protein biosynthesis by specifically cleaving a unique phosphodiester bond in 
the large ribosomal RNA subunit (Schindler and Davies, 1977; Endo and Wool, 1982). 
This bond is of particular interest because it is located at a universally conserved site 
with important roles in ribosome function (Wool et al., 1992). This site is known as the 
sarcin-ricin loop (SRL), because it is the target for the toxins α-sarcin and ricin, best 
representatives of ribotoxins and ribosome inhibiting proteins (RIPs), respectively. Such 
similarity in their action is the reason why ribotoxins were suggested to be included in 
the RIPs family, but some authors (Nielsen and Boston, 2001; Peumans et al., 2001) 
claim that this name should be restricted to plant N-glycosidases that depurinate a single 
nucleotide contiguous to the phosphodiester bond cleaved by ribotoxins.  
Seven proteins produced by Aspergillus have been described as ribotoxins to date, 
together with six from Penicillium and two more from Neosartorya glabra and 
Hirsutella thompsonii, and genes have been characterised in five additional strains of 
the first genus (Jennings et al., 1965; Olson and Goerner, 1965; Arruda et al., 1992; Lin 
et al., 1995; Huang et al., 1997; Wirth et al., 1997; Martínez-Ruiz et al., 1999a; Kao et 
al., 2001, Herrero-Galán et al., 2008). α-Sarcin, restrictocin and Asp f 1 are the most 
exhaustively characterised members of the family. These proteins show a high degree of 
conservation, displaying amino acid sequence similarities above 85 per cent (Figure 1). 
However, hirsutellin A (HtA), an extracellular protein produced by the invertebrate 
fungal pathogen Hirsutella thompsonii, has been recently demonstrated to be a ribotoxin 
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(Herrero-Galán et al., 2008), though it displays only about 25 per cent sequence identity 
with previously known members of the same family (Figure 1) (Boucias et al., 1998; 
Martínez-Ruiz et al., 1999b; Herrero-Galán et al., 2008). This suggests that ribotoxins 
are more widely distributed among fungi than previously believed (Martínez-Ruiz et al., 
1999a). 
Ribotoxins belong to a larger group of fungal extracellular unspecific RNases that show 
a high degree of sequence and structural similarity to those of the α-sarcin family but 
are not cytotoxic (Figures 1 and 2). RNase T1 is the best known representative of this 
family, as well as one of the most exhaustively characterised enzymes (Heinemann and 
Hahn, 1989; Gohda et al., 1994; Zegers et al., 1994, 1998; Steyeaert, 1997; Arni et al., 
1999; Loverix and Steyaert, 2001). RNase U2 from Ustilago sphaerogena also stands 
out as the unspecific fungal extracellular RNase most closely related to ribotoxins 
(Sacco et al., 1983; Martínez del Pozo et al., 1988; Martínez-Ruiz et al., 1999a). 
Ribotoxins share with RNases of the T1 family their main structural core but contain 
longer and positively charged loops (Figure 2). So, these loops are supposed to be 
essential for their specific toxicity (Martínez del Pozo et al., 1988), which gives rise to 
the hypothesis that a T1-like RNase could have acquired ribosome specificity and 
membrane interacting ability by the insertion of short recognition domains (Lamy et al., 
1992; Kao and Davies, 1995). Thus, the study of the evolution and mechanism of action 
of ribotoxins is of particular interest, as it could lead to the identification of the 
structural determinants that have allowed these proteins to become such efficient toxins, 
which would be a major step towards their biomedical utilisation as weapons against 
different human pathologies. Comparative structural and functional studies between 
ribotoxins and RNases from the T1 family are crucial in the course for achieving that 
goal. 
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Structure 
Ribotoxins are basic proteins of 149-150 amino acids with a high degree of identity, 
including two disulfide bridges conserved along the whole family (Figure 1) (Rodríguez 
et al., 1982; Sacco et al., 1983; López-Otín et al., 1984; Fernández-Luna et al., 1985; 
Arruda et al., 1990; Wirth et al., 1997; Martínez-Ruiz et al., 1999b). This observation 
includes HtA, although it is 20 residues shorter than the other known ribotoxins 
(Martínez-Ruiz et al., 1999b). Sequence differences are mainly concentrated at the 
loops, where ribotoxins also differ from RNases of the T1 family (Figure 2) (Martínez-
Ruiz et al., 1999a).  
The three dimensional structures of restrictocin (Yang and Moffat, 1996; Yang et al., 
2001) and α-sarcin (Pérez-Cañadillas et al., 2000, 2002; García-Mayoral et al., 2005a) 
have been elucidated. For α-sarcin, nuclear magnetic resonance and other techniques 
have been used to make a very detailed map of its structural and dynamic properties 
(Campos-Olivas et al., 1996a, 1996b; Pérez-Cañadillas et al., 2000, 2002; García-
Mayoral et al., 2005a, b). This protein folds into an α+β structure with a central five-
stranded antiparallel β-sheet and an α-helix of almost three turns (Figure 2). The sheet 
is composed of strands β3, β4, β5, β6 and β7, arranged in a -1, -1, -1, -1 topology. It is 
highly twisted in a right-handed sense, defining a convex face against which the α-helix 
is orthogonally packed, and a concave surface that holds the active site residues: His 50, 
Glu 96, Arg 121 and His 137, all of them with their side chains projecting outwards 
from the cleft. This main structural core, including the active site, is conserved among 
all fungal extracellular RNases, the α-helix being longer in the T1 family. Major 
differences are concentrated in the loops of non periodic structure and the amino 
terminal region. In ribotoxins, residues 1-26 form a long β-hairpin that can be 
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considered as two consecutive minor β-hairpins connected by a hinge region. The first 
one is closer to the open end of the hairpin, whereas the second sub-β-hairpin is formed 
by two short strands, β1b and β2b, connected by a type I β-turn. This last part of the N-
terminal hairpin is exposed to the solvent and shows a high mobility (Pérez-Cañadillas 
et al., 2002). The secondary structure elements are connected by large loops of non 
periodic structure but with very well defined conformations, maintained by a complex 
network of intraloop and interloop interactions, including hydrogen bonds, hydrophobic 
interactions and salt bridges (Yang and Moffat, 1996; Pérez-Cañadillas et al., 2000). 
From a dynamic point of view, NMR studies have shown that these loops undergo fast 
internal motions, ranging from picoseconds to nanoseconds (Pérez-Cañadillas et al., 
2002). Loop 2 of α-sarcin, one of the regions exhibiting more differences with RNases 
from the T1 family, deserves special attention because of its functional implications. It 
is rich in Gly and Lys residues, largely solvent exposed and highly mobile, though very 
well defined. In this loop, the stretch comprising residues 52-54 is essentially frozen 
within the molecular framework and includes Asn 54, a conserved residue among 
fungal extracellular RNases (Mancheño et al., 1995a) that establishes a hydrogen bond 
between its amide side chain proton and the carbonyl group of Ile 69. This interaction is 
also conserved in RNases from the T1 family (Sevcik et al., 1991; Pfeiffer et al., 1997; 
Hebert et al., 1998) and it has been suggested that this region could form the substrate 
recognition pocket in restrictocin (Yang and Moffat, 1996), a hypothesis that was later 
confirmed by the results obtained with α-sarcin Asn 54 mutants, located in the 
equivalent region of this protein (53-56).  
Thermal denaturation studies, by both differential scanning calorimetry (DSC) and 
circular dichroism (CD) measurements, have certified the high stability of ribotoxins 
(Gasset et al., 1995a). The presence of eight Tyr and two Trp residues has allowed a 
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great variety of spectroscopical studies, some of them leading to the determination of 
the pKa values corresponding to pH-induced conformational transitions (Martínez del 
Pozo et al., 1988; De Antonio et al., 2000). These results were completed later by the 
assignment, thanks to NMR measurements and predictions, of the pKa values of all 
titratable residues in the molecule (Pérez-Cañadillas et al., 1998; García-Mayoral et al., 
2003). Such a detailed structural characterisation has culminated with the determination 
of the different tautomeric states of every histidine residue in the protein (Pérez-
Cañadillas et al., 2003). 
Finally, as far as the active site is concerned, it is important to mention that it is 
composed of, at least, Tyr 48, His 50, Glu 96, His 137, Arg 121 and Leu 145, although 
only three of them (His 50, Glu 96 and His 137) are directly involved in proton transfer 
during the catalysis (Lacadena et al., 1999; Martínez-Ruiz et al., 2001). These three 
residues present unusual pKa values, and the two histidines adopt unusual tautomeric 
forms, which is a common feature of microbial RNases. In addition, His 137 establishes 
an important hydrogen bond with a backbone oxygen in loop 5. This loop is in part 
responsible for the low surface accesibility of all titrable atoms, which translates into 
important restrictions for the substrate, as will be discussed below (Pérez-Cañadillas et 




Both ribotoxins and T1-like RNases act as acid cyclising RNases, following a two-step 
mechanism (Figure 3) (Lacadena et al., 1998). This mechanism, as well as the roles of 
most of the residues forming its active site, have been clearly established for RNase T1 
(Steyeaert, 1997; Loverix and Steyaert, 2001; Yoshida, 2001). In the first step, a 
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transphosphorylation reaction occurs to form a 2’,3’-cyclic phosphate intermediate. 
Secondly, this intermediate is hydrolysed to the corresponding 3’-phosphate (Figure 3).  
This mechanism is shared by most RNases and is based on the general acid-base type 
endonucleolytic cleavage of RNA. However, the type of substrate (single or double 
stranded RNA), the specificity, the catalytic residues and the parameters defining the 
enzyme vary depending on the family. RNases from the T1 family can hydrolyse single 
stranded RNA, acting specifically on 3’-GpN-5’ sequences. RNase U2 is an exception, 
cleaving additionally 3’-ApN-5’ bonds (Egami et al., 1980). RNase T1 optimum 
activity occurs at pH values around neutrality, whereas RNase U2 reaches its highest 
efficiency at acid pH (Arima et al., 1968a, b; Uchida and Egami, 1971). Analysis of the 
cleavage reactions performed by α-sarcin against different dinucleoside 
monophosphates proved that this protein is also a cyclising RNase with an optimum pH 
of 5.0 (Lacadena et al., 1998, 1999; Pérez-Cañadillas et al., 1998). However, ribotoxins 
are much more exquisite enzymes, their specificity going further than a single 
preference for a type of nucleotide. As it has been already mentioned, ribotoxins exert 
their ribonucleolytic action on a single phosphodiester bond at the SRL, the one 
between G4325 and A4326 in 28S rRNA (rat ribosome numbering; G2661-A2662 in E. 
coli), releasing the so-called α fragment (488 bp in the rat ribosome) (Schindler and 
Davies, 1977; Endo and Wool, 1982; Endo et al., 1983, 1988). This single cut is enough 
to inhibit protein biosynthesis, as it interferes with elongation factors function (Brigotti 
et al., 1989; Wool et al., 1992). Finally, cell death by apoptosis occurs (Olmo et al., 
2001). 
There is evidence that all ribotoxins isolated to homogeneity conserve their specificity 
in the nanomolar range. However, at micromolar concentrations they are capable of 
hydrolising RNA exhaustively, exhibiting preference for guanine at the 3’-end (Endo et 
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al., 1983). This loss of specificity is shown by the hydrolysis of different substrate 
analogues, as it is the case of homopolymers such as poly(A), poly(G) or poly(I) (Endo 
et al., 1983). Activity has been detected even on dinucleoside monophosphates, which 
can be considered as their minimum substrate, though the way they are recognised by 
the enzyme seem to differ from the natural substrate. Despite of this, the advantage in 
this case is that the products, substrates and intermediates of the reaction can be 
separated and quantified by HPLC, providing information about the different steps of 
the catalysis (Lacadena et al., 1998). This kind of studies have allowed the 
establishment of the mechanism followed by ribotoxins when performing their 
ribonucleolytic action, the non-cytotoxic microbial RNases T1 and U2 being of great 
help as reference models. Accordingly,  α-sarcin behaves as a cyclising RNase, 
following  the same general reaction scheme as the other members of the RNase T1 
family (Figure 3). The production and characterisation of many site-directed and 
randomly produced mutants have allowed the determination of not only the ribotoxin 
residues involved in the catalytic reaction, but also their different roles during the 
cleavage of a phosphosiester bond. All the identified α-sarcin’s active site residues have 
their corresponding counterparts in RNase T1 (Figures 2 and 3). Residues His 137 and 
Glu 96 are essential for the catalytic reaction, acting as a general acid and a general 
base, respectively, during the first step and reversing their roles during the subsequent 
hydrolysis of the cyclic derivative (Brandhorst et al., 1994; Kao and Davies, 1995, 
1999; Lacadena et al., 1995, 1999; Sylvester et al., 1997; Kao et al., 1998). His 50 
would also contribute to the stabilisation of the transition state but, in this case, would 
not be able to substitute for Glu 96 as the general base in the E96Q mutant (Lacadena et 
al., 1999), as it is the case for the equivalent RNase T1 His residue (Steyaert et al., 
1990, 1997). Mutagenesis studies with residues Arg 121, Leu 145 and Tyr 48 have 
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confirmed their participation in the protein function (Masip et al., 2001, 2003; Álvarez-
García et al., 2006). Arg 121 is involved in the correct orientation of large substrates in 
the active site and its positive charge is essential for the interaction of the protein with 
membranes (Masip et al., 2001). Leu 145 interacts with His 137, contributing to the low 
pKa of this histidine residue, and keeps relation to the particular orientation of loop 5, 
which diminishes the accessibility of the active site to the solvent (Masip et al., 2003). 
Finally, mutation of residue Tyr 48 to Phe gives rise to a variant that is inactive against 
ribosomes but keeps the ability to degrade ApA, which reveals the essential role of the 
OH group in the phenolic ring in degradation of polymeric RNA (Álvarez-García et al., 
2006). Thus, Tyr 48, Arg 121 and Leu 145 appear to be determinants of the ribotoxin 
activity of α-sarcin. In the crystal geometric complex of RNase T1 with the minimal 
substrate 3’-GMP (Loverix and Steyaert, 2001), their counterpart residues Tyr 38, 
Arg77 and Phe 100 also appear to be part of the catalytic site of the enzyme. There has 
been speculation that these three residues, together with His 40, would form a 
prearranged structural and dielectric microenvironment that is complementary in shape, 
charge and hydrogen-bonding formation to the equatorial oxygens of the transition 
state, contributing to its optimal solvation/desolvation during the catalysis (Loverix and 
Steyaert, 2001). Additionally, studies on the crystal structures of complexes of 
restrictocin with inhibitors led to the proposal that ribotoxins may use base flipping to 
enable cleavage at the correct site of the SRL (Yang et al., 2001). All studies so far 
suggest that residues Tyr 48, Arg 121 and Leu 145 would enable the base flipping 
performed by the catalytic triad that permits RNase cleavage at a unique phosphodiester 
bond (Yang et al., 2001).  
Despite of all these conclusions being obtained throughout dinucleoside phosphates 
assays, the catalytic efficiency of ribotoxins against these substrates is several orders of 
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magnitude lower than that of T1-like RNases (Lacadena et al., 1998). One of the main 
reasons for this behavior is the solvent restriction imposed on the active site by the 
surrounding loops, especially loop 5. Length and interactions of this loop with the 
amino terminal hairpin affect the environment of the principal catalytic histidine (His 
137 in α-sarcin). This observation would explain the differences in catalytic efficiency, 
but not in specificity, leading to the suggestion that there might be interactions of the 
substrate with other loops.  
In summary, the main advantage of ribotoxins over T1-like RNases relies on their 
specificity, which makes them capable of inhibiting protein biosynthesis by cleaving a 
single bond out of more than 7000 present in the ribosome.  
 
Interaction with the ribosome 
This specificity, which makes these proteins extraordinarily efficient toxins, depends on 
the recognition of a very specific region within the ribosome. The SRL is located at 
domain VI of 28S rRNA (23S in prokaryotes) and is composed of 30-35 nucleotides of 
double stranded RNA with a universally conserved sequence and a compact structure 
that contains several purine-purine base pairs, a GAGA tetraloop, and a bulged 
guanosine adjacent to a reverse Hoogsteen AU pair.  This structure is stabilised by an 
unusual set of cross-strand base-stacking interactions and imino proton to phosphate 
oxygen hydrogen bonds (Figure 4) (Szewczak et al., 1993; Szewczak and Moore, 1995; 
Seggerson and Moore, 1998). Together with the ribosomal protein L11-binding region, 
the L7/L12 stalk, and the ribosomal proteins L6 and L14 (Figure 4), the SRL constitutes 
a binding site for elongation factors that is required for correct ribosome function (Endo 
and Wool, 1982; Cameron et al., 2002; Van Dyke et al., 2002). The L11-binding 
domain sequence is also universally conserved, in good agreement with its essential role 
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(Mears et al., 2002). Interestingly, the spatial orientation in the ribosome of both the 
SRL and the L11-binding domain varies not only among the different phyla 
(Ramakrishnan and Moore, 2001; Mears et al., 2002; Uchiumi et al., 2002), but also 
during the different steps of peptide bond formation (Gabashvili et al., 2000). These 
variations might explain why different toxins display different affinities when assayed 
against distinct ribosomal substrates (Schindler and Davies, 1977; Endo and Wool, 
1982; Wool et al., 1992; Uchiumi et al., 2002). Mutations affecting the sequence 
contained in the SRL result in deffective binding of elongation factors and aminoacyl-
tRNA, as well as a decreased translational fidelity (Liu and Liebman, 1996). Some of 
those mutations are lethal, reinforcing the importance of this region for the translational 
machinery (Leonov et al., 2003). Studies on the dynamics and kinetics of the ribosome 
show considerable mobility of this region, known as the GTPase centre, and its potential 
involvement in conformational changes essential for the correct performance of 
translation (Nilsson and Nissen, 2005).  
Recognition of the SRL by ribotoxins mainly depends on interactions between the 
protein and both the GAGA tetraloop and the bulged G (Moazed et al., 1988; Glück and 
Wool, 1996; Munishkin and Wool, 1997; Pérez-Cañadillas et al., 2000). G2655 is the 
most critical site for binding of elongation factors and it seems to be the only really 
essential nucleotide for the specific ribonucleolytic activity of ribotoxins (Macbeth and 
Wool, 1999). However, the primary determinant of recognition does not seem to be the 
type of nucleotide, but rather the SRL conformation (Munishkin and Wool, 1997; 
Correll et al., 1999; Correll and Swinger, 2003). As can be deduced from the crystal 
structure of the restrictocin-SRL analogue complex, loops 1 and 3 of the ribotoxin 
interact with the bulged G and the S-turn, which includes this nucleotide (Figure 5) 
(Macbeth and Wool, 1999; Yang et al., 2001). Some residues of loop 5 and loop 2, the 
 - 13 - 
latter comprising an abundance of positive charge residues, would be involved in 
interactions with the GAGA tetraloop including the target bond. Once the ribotoxin is 
anchored, it exerts its action on the GA bond 12 Å distant from the bulged G, though 
participation of a G in the cleaved bond does not seem to be strictly necessary (Glück 
and Wool, 1996).  
Nevertheless, all these interactions with the SRL do not explain by themselves the 
exquisite specificity of ribotoxins against their target ribosomes. Accordingly, it has 
been recently shown that the ribosomal context enhances the reaction rate several orders 
of magnitude, probably due to favorable electrostatic interactions (Korennykh et al., 
2006, 2007). Ribotoxins are basic proteins with a high density of charged and polar side 
chains exposed to the solvent (Pérez-Cañadillas et al., 2000), which would agree with 
an electrostatic localisation of ribotoxins to the ribosome and subsequent difussion 
within the ribosomal electrostatic field to the SRL. Additionally, the high internal 
mobility exhibited by some regions of the ribotoxins structure would enable 
accessibility of these proteins to other potential recognition sites, which would increase 
the probability of successful binding. In this regard, one of the regions with the highest 
conformational flexibility in α-sarcin is the N terminal β-hairpin (amino acids 1-26) 
(Pérez-Cañadillas et al., 2000; García-Mayoral et al., 2005a). Obtention of the deletion 
mutants α-sarcin ∆ (7-22) and Asp f 1 ∆(7-22) made it possible to assess that these 
variants maintained the ribonucleolytic activity against dinucleoside phosphates, as well 
as the ability to specifically degrade oligonucleotides mimicking the sequence and 
structure of the SRL, but could not act against intact ribosomes, resulting to be much 
less cytotoxic proteins (García-Ortega et al., 2002, 2005). The three-dimensional 
structure of the mentioned α-sarcin deletion mutant showed that the general folding of 
the wild-type protein was preserved, including the spatial conformation of the loops of 
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non periodic structure (García-Mayoral et al., 2004). Modeling the ribotoxin recognition 
of ribosomes by both wild-type α-sarcin and its ∆ (7-22) mutant, two additional 
interacting regions were identified (García-Mayoral et al., 2005b). One of them would 
involve a sequence stretch of loop 2 and ribosomal protein L6, whereas the other would 
depend on the contact between the N terminal β-hairpin and ribosomal protein L14 
(Figure 6). This latter interaction would not be possible for the ∆ (7-22) mutant, thus 
being crucial for the specific recognition of the ribosomes, as proved by the results 
obtained with this variant. This conclusion is supported by the observation that a 
sequence homologous to the 11-16 region of α-sarcin can be found in EF-2 from 
Saccharomyces cerevisiae (Kao and Davies, 1999; García-Mayoral et al., 2005b). 
Additionally, sequence variability in this region among proteins of the L14 family 
would explain the different specificity exhibited by ribotoxins depending on the species 
from which the ribosomes assayed are obtained (Schindler and Davies, 1977; Endo and 
Wool, 1982; Endo et al., 1983; Uchiumi et al., 2002; García-Mayoral et al., 2005b).  
In summary, all these interactions contribute to the extraordinary specificity of 
ribotoxins against their substrate, inactivating it with a second order rate constant (kcat / 
KM  = 1.7 x 1010M-1s-1) that matches the catalytic efficiency of the fastest known 
enzymes (Korennykh et al., 2006). This specific action is so effective that a single 
molecule of α-sarcin is enough to kill a cell (Lamy et al., 1992). 
 
Interaction with membranes and citotoxicity 
In order to completely explain the cytotoxic character of ribotoxins, mention must be 
made of their ability to interact with cell membranes. This is the main difference 
between ribotoxins and RNases from the T1 family, as well as the limiting factor for 
cytotoxicity. Although knowledge about the mechanism of cell entry followed by 
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ribotoxins is very scarce, the most relevant data concerning this topic have been 
obtained for α-sarcin.  
Studies with vesicle-model systems proved that α-sarcin interacts specifically with acid 
phospholipid vesicles, such as phosphatidilserine (PS) or phosphatidilglycerol (PG), at 
neutral or slightly acid pH (Gasset et al., 1989, 1991a). This fact would be in agreement 
with the preference exhibited by ribotoxins for tumour or virus-infected target cells, 
where the loss of simmetry in the plasma membrane induces a higher exposure of PS or 
other acid phospholipids to the extracellular medium (Bergelson et al., 1970; Turnay et 
al., 1993; Orntoft and Vestergaard, 1999; Ran et al., 2002; Papo and Shai, 2005). The 
recent discovery of the involvement in malignant transformation of the enzymes 
responsible for phosphatidic acid synthesis (diacylglycerol kinases) seems to further 
support this hypothesis (Filigheddu et al., 2007; Griner and Kazanietz, 2007; Mérida et 
al., 2008). Binding experiments allowed determination of  a Kd = 60.0 nM for lipid-
protein complexes that caused vesicle aggregation followed by fusion, but whose 
formation was abolished at basic pH (Gasset et al., 1990). In the initial step of this 
interaction, α-sarcin acts as a bridge to dimerise vesicles (Mancheño et al., 1994a) and 
then fusion is triggered by the destabilising effect of the protein, which simultaneously 
suffers conformational changes upon binding to the vesicles (Gasset et al., 1991b; 
Mancheño et al., 1994a). α-Sarcin is capable of translocating across the lipid bilayer of 
the vesicles thanks to a hydrophobic interaction involving region 116-139, as 
demonstrated by a synthetic peptide with that sequence (Oñaderra et al., 1993; Gasset et 
al., 1994, 1995b; Mancheño et al., 1995b). Even a peptide comprising only residues 
131-139 mimicks the effects of the whole protein in this respect (Mancheño et al., 
1998). Passage across membranes is accompanied by structural changes and a decrease 
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in protein stability, but the protein is ribonucleolytically active once inside the vesicle 
(Gasset et al., 1991b, 1995b; Oñaderra et al., 1993; Mancheño et al., 1994b).  
α-Sarcin ∆ (7-22) deletion mutant and some other variants affecting residues in this 
region of the protein have shown that the N terminal β-hairpin is also involved in the 
interaction with cell membranes (García-Ortega et al., 2001, 2002) as they display a 
different pattern of interaction with lipid vesicles, compatible with the absence of one 
vesicle-interacting protein region (García-Ortega et al., 2002). Restrictocin also behaves 
differently from α-sarcin as far as lipid-interacting abilities are concerned (García-
Ortega et al., 2001), being noteworthy the fact that six residues out of the only 20 
differences between both proteins are located in the N terminal β-hairpin. Loop 2 has 
been proposed by some authors to be involved as well in the interaction with 
membranes (Martínez del Pozo et al., 1988; Yang and Moffat, 1996; Kao and Davies, 
1999; Pérez-Cañadillas et al., 2000). The two triptophan residues of α-sarcin have not 
been proven necessary for the interaction (De Antonio et al., 2000), but studies with α-
sarcin’s R121Q mutant have demonstrated the important role played by Arg121 during 
this process (Masip et al., 2001). This interesting result led to the proposal that proteins 
that had evolved to interact with RNA, such as ribotoxins, would have developed 
structural and chemical determinants to recognise polyphosphate lattices that might as 
well allow recognition of a phospholipid bilayer (Masip et al., 2001). Interestingly, 
when the crystalline structure of restrictocin was elucidated, Arg 120, the counterpart to 
α-sarcin’s Arg 121, was found to be hydrogen bonded to a cocrystallised phosphate 
molecule at the active site (Yang and Moffat, 1996).  
In general, the basic character of ribotoxins seems to be one of the key factors for 
cytotoxicity, as has been shown for other RNases (Di Donato et al., 1994; Vatzaki et al., 
1999; Ilinskaya et al., 2002). Passage across the cell membrane is the rate-limiting step 
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for α-sarcin’s cytotoxic activity (Turnay et al., 1993), endocytosis being the 
internalisation mechanism (Olmo et al., 2001). As no protein receptor has been found so 
far, the toxic specificity must be related to a differential interaction with the lipid 
components of the membranes. α-Sarcin has been reported to be a powerful inhibitor of 
protein synthesis in picornavirus-infected cells and several transformed cell lines 
(Fernández-Puentes and Carrasco, 1980; Carrasco and Esteban, 1982; Turnay et al., 
1993; Olmo et al., 2001; Stuart and Brown, 2006). Besides, ionophores, external ATP 
or phospholipase C treatment made mammalian cells more sensitive to α-sarcin entry 
(Alonso and Carrasco, 1981, 1982; Otero and Carrasco, 1986, 1988). All these 
observations were interpreted in terms of the existence of altered membrane 
permeability. The toxin reaches the cytosol after clathrin-independent transport by acid 
endosomes and the Golgi (Olmo et al., 2001). In this regard, it has been recently shown 
that polycationic proteins tend to associate with phosphatidylserine enriched 
compartments such as endosomes (Yeung et al., 2008). The abundance of anionic 
phospholipids in the cytosolic leaflet of these organelles might be directly related to 
ribotoxins’ cytotoxicity. 
Studies with rhabdomyosarcoma cells  proved that apoptosis is the mechanism of cell 
death, although it does not seem to be a general direct consequence of protein 
biosynthesis inhibition, as deduced from a comparative analysis of the effects of  α-
sarcin and cycloheximide (Olmo et al., 2001). However, variants with mutations 
affecting the enzymatic specificity of the protein showed diminished cytotoxic effects 
on these cells, revealing the relationship between ribonucleolytic activity and 
cytotoxicity (Lacadena et al., 1995; García-Ortega et al., 2002). 
 
Evolution 
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Ribotoxins are an intriguing group of proteins regarding structure-function 
relationships. Their high degree of sequence and structural similarity with nontoxic 
fungal RNases of the T1 family has led to the suggestion that both families could have a 
common ancestor (Lamy et al., 1992; Kao and Davies, 1995). Comparing ribotoxins 
and T1-like RNases,  25 per cent sequence homology can be found (Sacco et al., 1983), 
as well as the conservation of the main structural core including the active site 
responsible for the phosphodiesterase activity of these enzymes (Pérez-Cañadillas et al., 
2000) (Figures 1 and 2). RNase U2 stands out as the unspecific fungal extracellular 
RNase most closely related to ribotoxins (Sacco et al., 1983; Martínez del Pozo et al., 
1988; Martínez-Ruiz et al., 1999a). It is 10 residues longer than the rest of the proteins 
of the T1 family (114 vs 101-106) and displays 34 per cent sequence identity with 
ribotoxins. These are the reasons why both families are considered as members of the 
same group of proteins (Aravind and Koonin, 2001).  
However, ribotoxins present a number of characteristics that make them unique within 
this superfamily. They are around 40 residues longer, basic, and show a high specificity 
for their natural substrate, resulting besides cytotoxic due to their ability to interact with 
cell membranes (Lacadena et al., 2007). From a structural point of view, the main 
differences with T1-type RNases lie in length and arrangement of the loops of non 
periodic structure and the N terminal β-hairpin, these elements being thus considered as 
the determinants of the extra activities of ribotoxins. Consequently, the study of the 
evolution of these proteins is of particular interest, as they appear to be naturally 
engineered target toxins that could have evolved from a nontoxic microbial RNase 
(Lamy et al., 1992; Kao and Davies, 1995), maybe from a guanine or purine specific 
one. If so, it would be reasonable to consider the existence of evolutionary intermediates 
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that could have acquired only some of the extra regions conferring additional activities 
to these RNases.  
After its discovery, hirsutelin A (HtA), an insecticidal protein from the mite fungal 
pathogen Hirsutella thompsonii, appeared as a feasible candidate to be such 
intermediate (Martínez-Ruiz et al., 1999b). Some of its biological properties resembled 
those of the ribotoxin family (Liu et al., 1996) and the alignment of the primary 
structure deduced from the HtA cDNA sequence (Boucias et al., 1998) with those of 
ribotoxins revealed a significant similarity (Martínez-Ruiz et al., 1999b). Sequence 
identity between HtA and ribotoxins was instead of only about 25 per cent, a value 
much lower than that among known ribotoxins (always above 60 per cent), but 
conservation of the catalytic residues and the four cysteines presumably involved in 
disulfide-bridges formation was observed (Figure 1). Interestingly, HtA is 20 residues 
shorter than α-sarcin-type proteins, the deletion of amino acids being presumably 
located at the protein loops and the N terminal hairpin, where HtA also differs from 
RNases of the T1 family. Characterisation of its enzymatic properties has shown that 
HtA specifically inactivates ribosomes releasing the α-fragment characteristic of 
ribotoxin activity on rRNA (Herrero-Galán et al., 2008). In addition, HtA specifically 
cleaves oligonucleotides that mimick the SRL, as well as selected polynucleotides and 
dinucleosides, behaving as a cyclising ribonuclease too (Herrero-Galán et al., 2008). 
Finally, it interacts with phospholipid membranes and exhibits cytotoxic activity on 
human tumour cells as the other ribotoxins (Herrero-Galán et al., 2008). Based on all 
these results, HtA has been considered as a new ribotoxin, resulting to be the smallest 
member so far described in this family. The characterisation performed (Herrero-Galán 
et al., 2008) proves that the abilities of ribotoxins can be accommodated into a shorter 
amino acid sequence of intermediate size between those of T1-type RNases and 
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previously known ribotoxins. Therefore, comparative studies with HtA can shed light 
on the structure-function relationships of this family of proteins, maybe revealing 
unknown roles of the longer loops of the other ribotoxins. In this regard, the current 
determination of its three-dimensional structure in solution by NMR (A. Viegas et al., 
unpublished) will be of great help. Additionally, the insecticidal character of HtA opens 
a new way for exploration of the biological function of ribotoxins, unknown to date. In 
this sense, it has been suggested that they could avoid destruction of the ribotoxin-
producing fungi deterring insect-feeding on their phialides (Brandhorst et al., 1996).  
 
Current trends 
Despite the fact that the potential use of ribotoxins as antitumour agents was abandoned 
early due to high toxicity (Roga et al., 1971), the present accumulation of data about 
their mechanism of action allows an optimistic view regarding the therapeutic utilisation 
of these proteins. In relation to this, studies on the allergenic character of some 
ribotoxins and the production of hypoallergenic mutants, together with the development 
of immunotoxins based on these fungal ribonucleases, stand out as the most feasible 
alternatives in the mid-term future. On the other hand, the design of chimaeric 
ribotoxins with convenient activities must also be considered. 
 
Allergenicity 
Allergens are usually identified as substances recognised by IgE antibodies contained in 
the sera of allergic patients. In this sense, ribotoxins have been related to allergies 
caused by Aspergillus, the main ribotoxin-producing genus and the most important 
pathogen involved in human allergic syndromes provoked by fungi (Kurup et al., 2002; 
Kurup, 2003). In fact, ribotoxins were found in the urine of patients with disseminated 
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aspergillosis (Arruda et al., 1990; Lamy et al., 1991) and antibodies have been used to 
prove that they accumulate in the vicinity of the nodes of fungal infection (Lamy et al., 
1991), Asp f 1 from Aspergillus fumigatus being the ribotoxin most deeply studied as an 
allergen. This protein is involved in the pathogenicity of allergic bronchopulmonary 
aspergillosis (ABPA), the most severe form of allergic inhalant diseases, as high levels 
of Asp f 1-specific IgE are found in the sera of patients affected by this syndrome 
(Kurup et al., 1994; García-Ortega et al., 2005). Asp f 1 was, besides, the first 
recombinant allergen tested in vivo (Moser et al., 1992), showing complete concordance 
with serologic determinations (Moser et al., 1992; Crameri et al., 1998; Hemmann et 
al., 1999). Unfortunately, the recombinant protein is not devoid of cytotoxic activity 
and can trigger anaphylaxis.  
Attempts to improve diagnosis of allergic diseases are focusing on the employment of 
homogeneous preparations of recombinantly produced allergens, much easier to 
standardise than complex fungal extracts (Piechura et al., 1983; Crameri et al., 1998; 
Kurup et al., 2006). Recent studies with the Asp f 1 ∆ (7-22) deletion mutant have 
shown that one of the major allergenic determinants of this protein is located at the N 
terminal β-hairpin (García-Ortega et al., 2005). This region displays the highest 
sequence variability among ribotoxins (Figure 1) (Martínez-Ruiz et al., 1999a, b, 2001), 
and is highly flexible and solvent exposed (Pérez-Cañadillas et al., 2000; García-
Mayoral et al., 2004). Asp f 1 differs from α-sarcin in only 19 residues, but five of these 
differences are located at this N terminal β-hairpin. Responses of α-sarcin and its 
deletion mutant against Asp f 1-containing sera were even lower than that of Asp f 1 ∆ 
(7-22) mutant, indicating that the deleted portion, although important, is not the only 
allergenic epitope within the molecule and that the essential residues for the other 
determinants of the immunoreactivity are changed in wild-type α-sarcin (García-Ortega 
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et al., 2002, 2005). Despite this decrease in IgE reactivity, the prevalence of the three 
Asp f 1 variants remained essentially unaffected, and they retained most of the IgG 
epitopes  (García-Ortega et al., 2005). This fact, together with the absence of cytotoxic 
activity in these ribotoxins deletion variants, states them as promising molecules for use 
in immunomodulating therapy and diagnosis of Aspergillus hypersensitivity, though this 
possibility should still be corroborated by in vivo assays. With this purpose, 
development of an allergic murine system sensitised against Asp f 1 is currently under 
way (E. Álvarez-García et al., unpublished).  
 
Immunotoxins 
Immunotoxins have emerged as a powerful alternative for the treatment of a variety of 
human pathologies because of their ability to specifically direct their action to certain 
cell types. Immunotoxin design is based on the ‘magic bullet’ concept, introduced by 
Ehrlich in 1906, according to which these molecules would consist of a tissue-specific 
carrier that would deliver toxic agents to neoplasic tissues (Ehrlich, 1956; Sandvig and 
van Deurs, 2000). The discovery of monoclonal antibodies in 1975 allowed the 
preparation of new toxins specifically directed against particular tumour cells, thanks to 
their conjugation to immunoglobulins specific for cancer cell antigens. The targeting 
moiety of these first-generation immunotoxins was the whole antibody molecule 
(Kreitman, 2000). As the recognition sites for antigens are on the variable regions of 
immunoglobulins, further studies were performed to verify that Fab fragments, obtained 
after IgG papain digestion, retained the ability to interact with the epitopes (Ward et al., 
1989; Worn and Pluckthun, 2001), leading to the so called Fab or Fv immunotoxins, 
which were more easily internalised because of their smaller size (Brinkmann, 2000). 
The development of new technologies allowed the production of recombinant 
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immunotoxins, stabilized by a flexible peptide (scFv) or by a disulfide bridge between 
the variable domains (dsFv). These domains can be easily modified by genetic 
engineering, are more stable, and can be expressed in several organisms (Kreitman, 
2003; Li et al., 2004).  
Regarding the toxin moiety, different toxins from bacteria and several ribosome 
inhibiting proteins (RIPs) from plants or fungi, mainly ricin, have been employed for 
immunotoxin design (Ghetie et al., 1993; Engert et al., 1997; Schnell et al., 1998). The 
cytotoxic character of ribotoxins against carcinomas, together with their high 
thermostability, low immunogenicity and resistance to proteases, states them as ideal 
candidates for the construction of immunotoxins. Initial attempts were performed by 
chemical conjugation for restrictocin (Orlandi et al., 1988; Conde et al., 1989; Rathore 
and Batra, 1997a, b), mitogillin (Better et al., 1992) and α-sarcin (Wawrzynczak et al., 
1991; Rathore et al., 1997). Immunotoxins based on this latter protein offered promising 
results in preliminary assays (Wawrzynczak et al., 1991) but did not proceed to in vivo 
studies probably because of their large size, that could hinder correct internalisation, or 
because of low structural stability of the immunoconjugates. 
Second generation immunotoxins attempt to solve these problems by fusing the toxin to 
a single chain containing only the variable domains, needed for antigen recognition. 
Recombinant immunotoxins of this kind have been already obtained based on 
restrictocin (Rathore and Batra, 1997a, b). These single-chain immunotoxins (scFv-
IMTX) can be easily modified by genetic engineering to improve their cytotoxic activity 
or to diminish immunogenicity or unspecific toxicity in vivo. In relation to this, a single-
chain immunotoxin composed of the variable domains of the B5 monoclonal antibody 
bound to α-sarcin through a peptide containing a furine cleavage site (scFv-IMTXαS) 
has been recently produced in the methylotrophic yeast Pichia pastoris (Lacadena et al., 
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2005). The monoclonal antibody (mAb) B5 belongs to a family of mAbs directed 
against a LewisY-related carbohydrate antigen that is overexpressed on the surface of 
many carcinomas, including breast and colon solid tumours (Pastan and FitzGerald, 
1991). Different members of the family have been used as the targeting moiety in many 
immunotoxins, and three of them have been evaluated in phase I trials in cancer 
patients, with promising results (Pai et al., 1996; Brinkmann, 2000; Woo et al., 2008). 
As far as the expression system is concerned, Pichia pastoris has emerged as a robust 
heterologous host in which several immunotoxins have already been successfully 
produced extracellularly (Woo et al., 2002, 2004, 2006; Liu et al., 2005).  
In this sense, scFv-IMTXαS produced in P. pastoris displays the characteristic 
ribonucleolytic activity and specific cytotoxicity of α-sarcin against targeted cells 
containing the LewisY antigen (Lacadena et al., 2005; N. Carreras-Sangrà, unpublished). 
Studies on genetically engineered variants of this immunotoxin with increased stability 
and affinity are currently being performed.  
 
Biotechnology 
In recent years, oral vaccination using Gram-positive bacteria as probiotics is being 
developed as a promising approach for treatment of several human pathologies, allergies 
included, thanks to the ‘Generally Regarded As Safe’ (GRAS) status of some of these 
microorganisms (Pouwels et al., 1996; Robinson et al., 1997; Kirjavainen et al., 1999; 
Maassen, 1999; Steidler et al., 2000). One of these Gram-positive bacteria is 
Lactococcus lactis, a non pathogenic, non invasive, non colonizing microorganism 
mainly used to produce fermented foods, but also proven useful, for example, in 
producing IL-10 for the treatment of inflammatory bowel disease in mice (Steidler et 
al., 2000). Although L. lactis passes rapidly through the gastrointestinal tract without 
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colonization (Gruzza et al., 1994; Klijn et al., 1995), genetically modified versions of 
this bacterium are still effective in delivering antigens to the mucosal immune system 
and capable of inducing a local immune response, which seems to happen because L. 
lactis lacks the ability to multiply in vivo but can readily be sampled by dendritic cells 
(Robinson et al., 1997; Maassen, 1999; Adel-Patient et al., 2005; Perez et al., 2005). 
This process seems to be involved in the development of efficient immune responses 
(Xin et al., 2003), including the selective induction of IgA (Macpherson and Uhr, 
2004). In addition, antigens within Lactococci are protected against direct contact with 
gastric acid and proteolytic enzymes.  
Following this idea, the Lactococcus lactis MG1363 strain has been recently engineered 
to produce and secrete wild-type Asp f 1 and α-sarcin, as well as three different mutants 
with reduced cytotoxicity and/or IgE-binding affinity, such as the above mentioned ∆ 
(7-22) variants of both proteins and H137Q active site mutant of α-sarcin (Álvarez-
García et al., 2008). The proteins were secreted in native and active form when the 
extracellular medium was buffered at pH values around 8.0. Intragastric administration 
of either the bacterial strain alone or the transformed producing wild-type α-sarcin did 
not induced any deleterious effect on mice intestinal tract, indicating that even the 
highly toxic protein could be safely delivered using this vehicle for oral administration 
(Álvarez-García et al., 2008). Lactococcus lactis utilisation as a potential delivery 
system for hypoallergenic variants of Asp f 1 and for ribotoxins in general as 
antitumoural agents against gastrointestinal tumours must thus be considered, though 
this possibility needs further evaluation. 
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Excellent movie on protein synthesis by ribosomes. 
 
http://www.fgsc.net 
One of the most popular Fungal Genetics web sites. A resource available for the Fungal 
Genetics research community with links to different Aspergillus genome sites 
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The Aspergillus web site. A worldwide comprehensive resource providing information 
about these fungi and the diseases they can cause. 
 
http://www.cbs.know.nl 
The Centraal Bureau Voor Schimmelcultures, an institute of the Royal Netherlands 
Academy of Science. 
 
http://rna.ucsc.edu/rnacenter/ribosome_movies.html 
Different movies on ribosome structure and protein biosynthesis. 
 
http://biochem4.okstate.edu/~biocukm/N1/N14212.html 




Link to a robust wheat germ cell-free protein synthesis system. 
 
http://rmn.iqfr.csic.es/ 
Connection to the RMN group where many of the ribotoxins’ three-dimensional 




Connection to Ira Wool Home Page, where many of the initial discoveries regarding 
ribotoxins were made. 




Figure 1. Sequence alignment of several ribotoxins (α-sarcin, gigantin, clavin, 
restrictocin and hirsutellin A) and RNases T1 and U2. Elements of secondary structure 
in α-sarcin are delimited at the top of the alignment, as well as the essential catalytic 
residues and the cysteines involved in disulfide bridges formation in ribotoxins. 
Positions conserved in the seven or at least four sequences are highlighted in black or 
grey, respectively. 
 
Figure 2. Representation of the three-dimensional structures of ribonucleases T1 
(Martínez-Oyanedel et al., 1991; PDB entry: 9RNT), U2 (Noguchi et al., 1995; PDB 
entry: 1RTU) and α-sarcin (Pérez-Cañadillas et al., 2000; PDB entry: 1DE3). Colour 
code for the secondary structure elements is the same as in Figure 1. Superpositions of 
the RNase U2 structure with those of RNase T1 and α-sarcin fitted to the active site 
residues are shown. The diagrams were generated with the MOLMOL program (Koradi 
et al., 1996).  
 
Figure 3. A: Catalytic mechanism proposed for cyclising ribonucleases. The type of 
substrate (dinucleotide, homo or heteropolynucleotide) is determined by R and R’. The 
catalytic residues A, B and C are represented within the active site structures of RNase 
T1 and α-sarcin in B. Essential residues are shown in red. The diagrams were generated 
with MOLMOL (Koradi et al., 1996).  
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Figure 4. A: Diagram showing the position of the SRL (red) in the structure of the 
Haloarcula marismortui large ribosomal subunit (PDB entry: 1JJ2). Ribosomal proteins 
L6 (green) and L14 (yellow) are also shown. B: Structure of the SRL. Bases are filled in 
the 5’ half and empty in the 3’ half of the sequence. Numbers correspond to rat or E. 
coli (in brackets) nucleotide positions within the 28S (23S) rRNA. Ribotoxins cleave 
the bond between G4325 (2661) and A4326 (2662) (grey). The bulged G4319 (2655) is 
also indicated. The diagrams were generated with VMD (Humphrey et al., 1996). 
 
Figure 5. Structure of a restrictocin-SRL analogue complex (Yang et al., 2001; PDB 
entry: 1JBS). The bulged G, interacting with loops 1 and 3 of the protein, and the 
nucleotides linked by the bond cleaved by ribotoxins are highlighted in black. The 
GAGA tetraloop is distorted in this substrate analogue and thus is not degraded. The 
diagrams were generated with VMD (Humphrey et al., 1996). 
 
Figure 6. Minimised docking model showing the interaction of wild-type α-sarcin (red) 
and its ∆ (7-22) deletion mutant (blue) (García-Mayoral et al., 2004; PDB entry: 430D) 
with the SRL and the Haloarcula marismortui ribosomal proteins L6 and L14. The 
diagrams were generated with MOLMOL (Koradi et al., 1996).  
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